Conductive communication vector selection based on physical and/or physiological state of patient
US-2024382766-A1 · Nov 21, 2024 · US
US2024315581A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2024315581-A1 |
| Application number | US-202418734980-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jun 5, 2024 |
| Priority date | Mar 29, 2017 |
| Publication date | Sep 26, 2024 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention generally relates to heart treatment systems. In some aspects, methods and systems are provided for facilitating communication between implanted devices. For example, an implantable cardiac rhythm management device may be configured to communicate with an implantable blood pump. The implantable cardiac rhythm management device may deliver heart stimulation rate information in addition to information associated with any detected abnormalities in heart function. In response, the pump may be configured to adjust pumping by the pump to better accommodate a patient's particular needs.
Opening claim text (preview).
What is claimed is: 1 . A method of assisting a heart of a patient, the method comprising: receiving, with a pump processor of an implantable blood pump coupled with a heart of a patient, electrical signals from an implanted cardiac device monitoring the heart of the patient, wherein the implanted cardiac monitoring device communicates with the implantable blood pump through conductive pathways through tissue; and adjusting a pumping protocol of the implantable blood pump based on the received electrical signals via conductive pathways with the pump processor. 2 . The method of claim 1 , wherein the implanted cardiac device communicates with the implantable blood pump through conductive pathways through tissue by emitting an electrical field conducted through tissue. 3 . The method of claim 2 , wherein receiving the electrical signals with the pump processor of the implantable blood pump comprises detecting the electrical field conducted through tissue with one or more sensors coupled to the implantable blood pump. 4 . The method of claim 1 , further comprising communicating bidirectionally among the implantable blood pump and the implanted cardiac device. 5 . The method of claim 1 , wherein the electrical signals comprise electrical sensing signals of the heart of the patient. 6 . The method of claim 1 , wherein the electrical signals comprise electrical signals corresponds to a pacing or defibrillation stimulation of the patient's heart. 7 . The method of claim 6 , wherein the electrical pacing signals are received by the pump processor with each heart stimulation pulse delivered to the heart of the patient by the implanted cardiac device. 8 . The method of claim 1 , wherein the implanted cardiac device comprises a leadless cardiac pacemaker. 9 . The method of claim 1 , further comprising determining with the pump processor of the implantable blood pump, a type of abnormal heart rhythm of the heart of the patient detected by the implanted cardiac device. 10 . The method of claim 9 , wherein the type of abnormal heart rhythm is determined to be a fibrillation of the heart, the pump processor adjusting the pumping protocol to cease pumping of the implantable blood pump for a predetermined duration of time. 11 . A heart treatment system, comprising: an implantable blood pump configured to couple with a circulatory system of a patient and to pump blood therethrough, the implantable blood pump comprising a pump processor and one or more sensors coupled to the implantable blood pump; and an implantable cardiac device configured to monitor a heart of the patient, wherein the implantable cardiac device is configured to communicate an electrical signal to the pump processor of the implantable blood pump through conductive pathways through tissue; wherein the one or more sensors of the implantable blood pump are configured to receive electric fields emitted by the implantable cardiac device and conducted through the tissue; and wherein the pump processor of the implantable blood pump is configured to adjust a pumping of the implantable blood pump based on the electrical signal received from the electric fields emitted by the implanted cardiac device. 12 . The heart treatment system of claim 11 , wherein the implantable cardiac device comprises a leadless cardiac pacemaker. 13 . The heart treatment system of claim 12 , wherein the leadless cardiac pacemaker is configured to communicate with the implantable blood pump through conductive pathways without any additional power for transmission. 14 . The heart treatment system of claim 12 , wherein the leadless cardiac pacemaker is configured to communicate with the implantable blood pump through conductive pathways without an antenna or telemetry coil. 15 . The heart treatment system of claim 11 , wherein the implantable blood pump and the implanted cardiac device are configured for bidirectional communication. 16 . The heart treatment system of claim 11 , wherein the electrical signal comprises an electrical sensing signal of the heart of the patient. 17 . The heart treatment system of claim 11 , wherein the electrical signal corresponds to a pacing or defibrillation stimulation of the patient's heart. 18 . The heart treatment system of claim 17 , wherein the electrical pacing signal is received by the pump processor with each heart stimulation pulse delivered to the heart of the patient by the implantable cardiac device. 19 . The heart treatment system of claim 11 , wherein the pump processor of the implantable blood pump is configured to determine a type of abnormal heart rhythm of the heart of the patient detected by the implantable cardiac device. 20 . The heart treatment system of claim 19 , wherein the type of abnormal heart rhythm is determined to be a fibrillation of the heart and wherein the pump processor is configured to cease the pumping of the implantable blood pump for a predetermined duration of time.
Centrifugal pumps · CPC title
the blood flow through the rotating member having both radial and axial components, e.g. mixed flow pumps · CPC title
drawing blood from a ventricle and returning the blood to the arterial system via a cannula external to the ventricle, e.g. left or right ventricular assist devices · CPC title
synchronous with the native heart beat · CPC title
Sensors arranged on or in the housing, e.g. ultrasonic flow sensors · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.